Study guide
13.1 Pharmacology Overview
COA Study Guide Exam
Track your progress as you read
Finished sections get a check mark.
1 Chapter 1: COA Orientation and Exam Strategy
1.1 Current COA Exam Facts 1.2 Eligibility, Application, and Scheduling 1.3 Blueprint Domains and Weighting 1.4 Question Style and Score Report Thinking 1.5 Study Calendar and Practice Plan
2 Chapter 2: History and Documentation
2.1 History and Documentation Overview 2.2 Core Workflows and Decision Points 2.3 Scenario Practice for History and Documentation 2.4 Common Traps in History and Documentation 2.5 Practice Drills and Readiness Markers
3 Chapter 3: Visual Assessment
3.1 Visual Assessment Overview 3.2 Core Workflows and Decision Points 3.3 Scenario Practice for Visual Assessment 3.4 Common Traps in Visual Assessment 3.5 Practice Drills and Readiness Markers
4 Chapter 4: Visual Field Testing
4.1 Visual Field Testing Overview 4.2 Core Workflows and Decision Points 4.3 Scenario Practice for Visual Field Testing 4.4 Common Traps in Visual Field Testing 4.5 Practice Drills and Readiness Markers
5 Chapter 5: Pupil Assessment
5.1 Pupil Assessment Overview 5.2 Core Workflows and Decision Points 5.3 Scenario Practice for Pupil Assessment 5.4 Common Traps in Pupil Assessment 5.5 Practice Drills and Readiness Markers
6 Chapter 6: Tonometry
6.1 Tonometry Overview 6.2 Core Workflows and Decision Points 6.3 Scenario Practice for Tonometry 6.4 Common Traps in Tonometry 6.5 Practice Drills and Readiness Markers
7 Chapter 7: Keratometry
7.1 Keratometry Overview 7.2 Core Workflows and Decision Points 7.3 Scenario Practice for Keratometry 7.4 Common Traps in Keratometry 7.5 Practice Drills and Readiness Markers
8 Chapter 8: Lensometry
8.1 Lensometry Overview 8.2 Core Workflows and Decision Points 8.3 Scenario Practice for Lensometry 8.4 Common Traps in Lensometry 8.5 Practice Drills and Readiness Markers
9 Chapter 9: Biometry
9.1 Biometry Overview 9.2 Core Workflows and Decision Points 9.3 Scenario Practice for Biometry 9.4 Common Traps in Biometry 9.5 Practice Drills and Readiness Markers
10 Chapter 10: Diagnostic Ultrasound
10.1 Diagnostic Ultrasound Overview 10.2 Core Workflows and Decision Points 10.3 Scenario Practice for Diagnostic Ultrasound 10.4 Common Traps in Diagnostic Ultrasound 10.5 Practice Drills and Readiness Markers
11 Chapter 11: Supplemental Testing
11.1 Supplemental Testing Overview 11.2 Core Workflows and Decision Points 11.3 Scenario Practice for Supplemental Testing 11.4 Common Traps in Supplemental Testing 11.5 Practice Drills and Readiness Markers
12 Chapter 12: Microbiology
12.1 Microbiology Overview 12.2 Core Workflows and Decision Points 12.3 Scenario Practice for Microbiology 12.4 Common Traps in Microbiology 12.5 Practice Drills and Readiness Markers
13 Chapter 13: Pharmacology
13.1 Pharmacology Overview 13.2 Mydriatics, Cycloplegics, and Anesthetics 13.3 Glaucoma, Anti-Infective, and Anti-Inflammatory Agents 13.4 Stains, Instillation Technique, and Safety Traps 13.5 Practice Drills and Readiness Markers
14 Chapter 14: Surgical Assisting
14.1 Surgical Assisting Overview 14.2 Core Workflows and Decision Points 14.3 Scenario Practice for Surgical Assisting 14.4 Common Traps in Surgical Assisting 14.5 Practice Drills and Readiness Markers
15 Chapter 15: Ophthalmic Patient Services and Education
15.1 Ophthalmic Patient Services and Education Overview 15.2 Core Workflows and Decision Points 15.3 Scenario Practice for Ophthalmic Patient Services and Education 15.4 Common Traps in Ophthalmic Patient Services and Education 15.5 Practice Drills and Readiness Markers
16 Chapter 16: Optics and Spectacles
16.1 Optics and Spectacles Overview 16.2 Core Workflows and Decision Points 16.3 Scenario Practice for Optics and Spectacles 16.4 Common Traps in Optics and Spectacles 16.5 Practice Drills and Readiness Markers
17 Chapter 17: Contact Lenses
17.1 Contact Lens Types, Parameters, and Oxygen 17.2 Fitting Workflows: K Readings, Tear Lens, and the SAM/FAP Rule 17.3 Insertion, Removal, Care Systems, and Wear Schedules 17.4 Complications: Hypoxia, Infiltrates, and Corneal Ulcers 17.5 Specialty Lenses, Multifocals, and Readiness Drills
18 Chapter 18: Equipment Maintenance and Repair
18.1 Equipment Maintenance and Repair Overview 18.2 Core Workflows and Decision Points 18.3 Scenario Practice for Equipment Maintenance and Repair 18.4 Common Traps in Equipment Maintenance and Repair 18.5 Practice Drills and Readiness Markers
19 Chapter 19: Medical Ethics, Legal, and Regulatory Issues
19.1 Medical Ethics, Legal, and Regulatory Issues Overview 19.2 Core Workflows and Decision Points 19.3 Scenario Practice for Medical Ethics, Legal, and Regulatory Issues 19.4 Common Traps in Medical Ethics, Legal, and Regulatory Issues 19.5 Practice Drills and Readiness Markers
20 Chapter 20: General Medical Knowledge
20.1 General Medical Knowledge Overview 20.2 Medical Terminology, Anatomy, and Physiology 20.3 Systemic Disease with Ocular Manifestations 20.4 Pharmacology and Medical Emergencies 20.5 Microbiology, Infection Control, and Readiness Drills
21 Chapter 21: Refraction
21.1 Refraction Overview 21.2 Core Workflows and Decision Points 21.3 Scenario Practice for Refraction 21.4 Common Traps in Refraction 21.5 Practice Drills and Readiness Markers
22 Chapter 22: Ophthalmic Imaging
22.1 Ophthalmic Imaging Overview 22.2 Core Workflows and Decision Points 22.3 Scenario Practice for Ophthalmic Imaging 22.4 Common Traps in Ophthalmic Imaging 22.5 Practice Drills and Readiness Markers
23 Chapter 23: Ocular Motility Testing
23.1 Ocular Motility Testing Overview 23.2 Core Workflows and Decision Points 23.3 Scenario Practice for Ocular Motility Testing 23.4 Common Traps in Ocular Motility Testing 23.5 Practice Drills and Readiness Markers
24 Chapter 24: Final Review and Test Day
24.1 Timed Practice Strategy 24.2 Last-Week Review Map 24.3 Exam-Day Checklist 24.4 After the Exam and Next Steps
13.1 Pharmacology Overview
Key Takeaways Explain This Topic AI
Pharmacology is roughly 6% of the COA blueprint; questions test drug classes, indications, concentrations, side effects, and instillation safety.
The four core diagnostic classes you must master are mydriatics (sympathomimetics), cycloplegics (anticholinergics), anesthetics, and stains.
Phenylephrine 2.5% dilates without cycloplegia; tropicamide 0.5-1% is the workhorse short-acting cycloplegic mydriatic.
Always know contraindications (narrow angles, cardiac disease with 10% phenylephrine) and the technician's instillation responsibilities.
Last updated: June 2026
13.1 Pharmacology Overview
Ophthalmic pharmacology is the study of drugs applied to or affecting the eye. On the Certified Ophthalmic Assistant (COA) exam administered by IJCAHPO (International Joint Commission on Allied Health Personnel in Ophthalmology) at Pearson VUE, pharmacology is approximately 6% of the roughly 200 multiple-choice questions you answer in a 3-hour sitting. That weight is small but high-yield: pharmacology questions are concrete, factual, and easy points if you have memorized drug classes, concentrations, and side effects.
What the COA must know
As an assistant you do not prescribe, but you routinely prepare, instill, document, and monitor topical agents under physician direction. The exam expects you to recognize each drug by class, mechanism, indication, concentration, onset, duration, and key adverse effect .
The core diagnostic drug classes
- Class Mechanism Example (concentration) Primary use
- Mydriatic (sympathomimetic) Stimulates iris dilator muscle Phenylephrine 2.5% Dilation without cycloplegia
Cycloplegic (anticholinergic) Blocks iris sphincter and ciliary muscle Tropicamide 0.5-1%, cyclopentolate 1% Dilation + paralyzed accommodation
Topical anesthetic Blocks sodium channels in corneal nerves Proparacaine 0.5%, tetracaine 0.5% Tonometry, foreign-body removal
Vital stain Stains epithelial defects / tear film Fluorescein, lissamine green, rose bengal Tonometry, abrasion, tear breakup
Mydriasis vs. cycloplegia (a classic distractor)
These terms are tested constantly and confused easily. Mydriasis is pupil dilation (the dilator pulls the iris open). Cycloplegia is paralysis of the ciliary muscle , which stops accommodation and produces blurred near vision. Phenylephrine causes pure mydriasis; it does NOT cycloplege. Tropicamide and cyclopentolate do both, but tropicamide is a relatively weak cycloplegic, which is why pediatric refraction relies on stronger cyclopentolate or atropine.
A worked example
A 7-year-old needs a cycloplegic refraction to uncover latent hyperopia. Tropicamide alone is insufficient because children have powerful accommodation. The physician orders cyclopentolate 1% , which gives reliable cycloplegia in 30-60 minutes. If the child were under 1 year, a lower concentration (cyclopentolate 0.5%) reduces systemic anticholinergic risk. The COA must know cyclopentolate can rarely cause CNS effects in children (ataxia, disorientation, drowsiness), so you observe the child afterward.
Trap to avoid
Do not assume "dilation" always means the same drop. The physician selects the agent based on the goal: quick exam dilation (tropicamide + phenylephrine), refraction (cyclopentolate), or therapeutic dilation to break a synechia (atropine, longest-acting). Read the stem for the clinical purpose before choosing the drug.
How drugs reach the eye
The COA should understand basic ophthalmic routes of administration , because the exam contrasts them. Topical drops and ointments are the most common; ointments stay longer but blur vision, so they are often reserved for bedtime. Subconjunctival and intravitreal injections deliver high local concentrations (anti-VEGF agents for macular degeneration are intravitreal). Oral and intravenous routes (acetazolamide, fluorescein angiography dye) act systemically. Periocular depot injections give prolonged delivery.
The eye's tear film and blink reflex wash most of a drop away within minutes, which is exactly why punctal occlusion and waiting between drops matter.
Reading a drug label
Every ophthalmic bottle states the active ingredient, concentration as a percentage , and the cap color convention used in the United States. Concentration is meaningful: phenylephrine 2.5% and 10% are very different drugs in terms of safety, and proparacaine 0.5% is the standard anesthetic strength. The COA verifies the label every time rather than relying on cap color alone, because look-alike bottles are a real source of error. When two answer choices name the same drug at different strengths, the safer or clinically appropriate concentration is usually correct.
Documentation expectations
Whenever you instill a drug, you record the agent, concentration, eye (OD = right, OS = left, OU = both), and time . Accurate timing matters because the physician needs to know dilation is adequate (about 20-30 minutes for tropicamide-phenylephrine) before examining the fundus. Sloppy documentation is a common distractor in scenario questions: the "best" answer instills correctly and records it.
Scope of practice for the assistant
The COA works under physician supervision and within delegated authority. You may instill diagnostic drops, perform dilation per protocol, and educate patients, but you do not independently diagnose, prescribe, or change a medication regimen. When a scenario describes a patient asking you to "just adjust" or "refill" a prescription, the safe answer routes the request to the physician. Recognizing the boundary between an assistant's delegated tasks and the physician's prescribing role is tested both here and in the ethics and patient-services domains.
Generic vs. brand and patient education
Patients often present a medication list mixing brand and generic names , and the COA should recognize common pairs: latanoprost (Xalatan), timolol (Timoptic), brimonidine (Alphagan), dorzolamide-timolol combinations (Cosopt), and prednisolone acetate (Pred Forte). Reconciling these accurately prevents duplicate-therapy errors. Patient education is part of the role too: teach correct drop technique, punctal occlusion , waiting between drops, and the importance of finishing an antibiotic course or not abruptly stopping glaucoma drops, since lapses raise IOP.
A well-instructed patient is a recurring "best answer" theme because adherence directly affects outcomes.